GPR109A activation induced the downregulation of proinflammatory IL-6 cytokine formation and the upregulation of anti-inflammatory IL-10 cytokine production, which might attenuate the development of chronic low-grade inflammation associated with cognitive impairment and aging [34]. Here, HCAR2 is linked to Cognitive impairment.